论文部分内容阅读
1.Efficacy of intravenous administration of mesenchymal stromal cells(MSCs)for myocardial infarction(MI)is limited by low cell retention.Previous studies indicated that remote ischemic conditioning could protect against ischemia–reperfusion-induced injury by release of variouscytokines including stromal cell derived factor-1 alpha(SDF-1α).